The U.S. dietary supplements market size is calculated at USD 71.60 billion in 2024, grew to USD 78.20 billion in 2025 and is predicted to be worth around USD 162.40 billion by 2033. The market is expanding at a CAGR of 9.47% between 2024 and 2033.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. U.S. Dietary Supplements Market, by Ingredient, 2024-2034
7.1.1. Vitamins
7.1.1.1. Market Revenue and Forecast (2021-2034)
7.1.2. Minerals
7.1.2.1. Market Revenue and Forecast (2021-2034)
7.1.3. Fibers and Specialty Carbohydrates
7.1.3.1. Market Revenue and Forecast (2021-2034)
7.1.4. Omega Fatty Acids
7.1.4.1. Market Revenue and Forecast (2021-2034)
7.1.5. Botanicals
7.1.5.1. Market Revenue and Forecast (2021-2034)
7.1.6. Proteins and Amino Acids
7.1.6.1. Market Revenue and Forecast (2021-2034)
7.1.7. Others
7.1.7.1. Market Revenue and Forecast (2021-2034)
8.1. U.S. Dietary Supplements Market, by Form, 2024-2034
8.1.1. Capsules
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Tablets
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Gummies
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Soft Gels
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Liquids
8.1.5.1. Market Revenue and Forecast (2021-2034)
8.1.6. Powders
8.1.6.1. Market Revenue and Forecast (2021-2034)
8.1.7. Others
8.1.7.1. Market Revenue and Forecast (2021-2034)
9.1. U.S. Dietary Supplements Market, by Type, 2024-2034
9.1.1. Otc
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Prescribed
9.1.2.1. Market Revenue and Forecast (2021-2034)
10.1. U.S. Dietary Supplements Market, by Function, 2024-2034
10.1.1. Additional Supplements
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Medicinal Supplements
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Sports Nutrition
10.1.3.1. Market Revenue and Forecast (2021-2034)
11.1. U.S. Dietary Supplements Market, by Application, 2024-2034
11.1.1. Energy and Weight Management
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Bone and Joint Health
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Diabetes
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. General Health
11.1.4.1. Market Revenue and Forecast (2021-2034)
11.1.5. Immunity
11.1.5.1. Market Revenue and Forecast (2021-2034)
11.1.6. Cardiac Health
11.1.6.1. Market Revenue and Forecast (2021-2034)
11.1.7. Gastrointestinal Health
11.1.7.1. Market Revenue and Forecast (2021-2034)
11.1.8. Anti-Cancer
11.1.8.1. Market Revenue and Forecast (2021-2034)
11.1.9. Lungs Detox/Cleanse
11.1.9.1. Market Revenue and Forecast (2021-2034)
11.1.10. Sexual Health
11.1.10.1. Market Revenue and Forecast (2021-2034)
11.1.11. Brain/Mental Health
11.1.11.1. Market Revenue and Forecast (2021-2034)
11.1.12. Skin/Hair/Nails
11.1.12.1. Market Revenue and Forecast (2021-2034)
11.1.13.2. Insomnia
11.1.13.1. Market Revenue and Forecast (2021-2034)
11.1.14. Anti-Aging
11.1.14.1. Market Revenue and Forecast (2021-2034)
11.1.15. Menopause
11.1.15.1. Market Revenue and Forecast (2021-2034)
11.1.16. Prenatal Health
11.1.16.1. Market Revenue and Forecast (2021-2034)
11.1.17. Others
11.1.17.1. Market Revenue and Forecast (2021-2034)
12.1. U.S. Dietary Supplements Market, by Distribution Channel, 2024-2034
12.1.1. Offline
12.1.1.1. Market Revenue and Forecast (2021-2034)
12.1.2. Online
12.1.2.1. Market Revenue and Forecast (2021-2034)
13.1. U.S. Dietary Supplements Market, by End User, 2024-2034
13.1.1. Adults
13.1.1.1. Market Revenue and Forecast (2021-2034)
13.1.2. Geriatric
13.1.2.1. Market Revenue and Forecast (2021-2034)
13.1.3. Pregnant Women
13.1.3.1. Market Revenue and Forecast (2021-2034)
13.1.4. Children
13.1.4.1. Market Revenue and Forecast (2021-2034)
13.1.5. Infants
13.1.5.1. Market Revenue and Forecast (2021-2034)
14.1. U. S.
14.1.1. Market Revenue and Forecast, by Ingredient (2021-2034)
14.1.2. Market Revenue and Forecast, by Form (2021-2034)
14.1.3. Market Revenue and Forecast, by Type (2021-2034)
14.1.4. Market Revenue and Forecast, by Function (2021-2034)
14.1.5. Market Revenue and Forecast, by Application (2021-2034)
14.1.6. Market Revenue and Forecast, by End User (2021-2034)
14.1.7. Market Revenue and Forecast, by Distribution Channel (2021-2034)
15.1. Bayer
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. NBTY Inc
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Bionova Lifesciences
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Nu Skin Enterprises
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Carlyle Group
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Pfizer
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Arkopharma Laboratoires Pharmaceutiques
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Glanbia
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Herbalife International
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Abbott Laboratories
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
17.1. About Us
17.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample